Chardan Capital
Upgrade grade
D
Downgrade grade
A
Chardan Capital Markets is a boutique investment bank founded in 2009 that has carved out a specialized niche in early-stage and growth-stage equity research coverage. The firm has built a focused platform around middle-market and micro-cap companies, establishing itself as a dedicated research voice for smaller public companies that often receive limited institutional attention. With approximately 950 analyst ratings in our database, Chardan demonstrates consistent engagement across US equities, particularly in sectors including healthcare, technology, and life sciences where they've developed particular expertise in emerging and developmental-stage businesses. What distinguishes Chardan's research culture is their willingness to cover companies at earlier stages of their public lifecycle and smaller market capitalizations where they provide detailed fundamental analysis often unavailable from larger traditional research shops, making them a valuable resource for investors seeking differentiated coverage of lesser-known names with significant growth potential.
Upgrades
35
71.43% win rate
· avg +3.30% D1
Downgrades
53
79.25% win rate
· avg -11.54% D1
Avg Gap — Upgrades
+4.85%
open vs prev close
Avg Gap — Downgrades
-10.48%
open vs prev close
Performance by Sector
| Sector | ↑ Win% | ↑ D1 | ↓ Win% | ↓ D1 |
|---|---|---|---|---|
| Healthcare | 59.09% (22) | +2.40% | 87.10% (31) | -17.78% |
| Technology | — | — | 71.43% (14) | -3.36% |
Win Rate by Year
| Year | ↑ Win% | ↑ Calls | ↓ Win% | ↓ Calls |
|---|
Recent Calls
| Date | Ticker | Company | Sector | Action | Grade Change | PT | Gap | D1 |
|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | NTLA | Intellia Therapeutics, Inc. | Healthcare | Maintains | Buy → Buy | — | +4.4% | -4.3% |
| Apr 23, 2026 | VFS | VinFast Auto Ltd. | Consumer Cyclical | Maintains | Buy → Buy | — | -2.6% | -6.0% |
| Apr 22, 2026 | ANRO | Alto Neuroscience, Inc. | Healthcare | Maintains | Buy → Buy | — | +2.5% | +6.1% |
| Apr 21, 2026 | PASG | Passage Bio, Inc. | Healthcare | Downgrade | Buy → Neutral | — | +2.1% | -1.1% |
| Apr 10, 2026 | IOVA | Iovance Biotherapeutics, Inc. | Healthcare | Maintains | Buy → Buy | — | -0.5% | -7.7% |
| Apr 9, 2026 | IBIO | iBio, Inc. | Healthcare | Maintains | Buy → Buy | — | -0.4% | -1.8% |
| Apr 9, 2026 | PRQR | ProQR Therapeutics N.V. | Healthcare | Maintains | Buy → Buy | — | +2.7% | +8.2% |
| Apr 8, 2026 | CLSK | CleanSpark, Inc. | Technology | Maintains | Buy → Buy | — | +8.8% | +9.1% |
| Apr 2, 2026 | ANRO | Alto Neuroscience, Inc. | Healthcare | Maintains | Buy → Buy | — | -14.6% | -7.4% |
| Mar 31, 2026 | PVLA | Palvella Therapeutics, Inc. | Healthcare | Maintains | Buy → Buy | — | +4.4% | +12.6% |
| Mar 30, 2026 | ZOOZ | ZOOZ Strategy Ltd. | Industrials | Maintains | Buy → Buy | — | +0.3% | -4.7% |
| Mar 30, 2026 | SNTI | Senti Biosciences, Inc. | Healthcare | Maintains | Buy → Buy | — | -1.3% | -2.3% |
| Mar 30, 2026 | MNPR | Monopar Therapeutics Inc. | Healthcare | Maintains | Buy → Buy | — | +0.1% | -1.5% |
| Mar 30, 2026 | ALMS | Alumis Inc. Common Stock | Healthcare | Maintains | Buy → Buy | — | -3.2% | -18.5% |
| Mar 27, 2026 | HYPD | Hyperion DeFi, Inc. | Healthcare | Maintains | Buy → Buy | — | +0.6% | -2.0% |
| Mar 27, 2026 | CGTX | Cognition Therapeutics, Inc. | Healthcare | Maintains | Buy → Buy | — | -0.9% | -32.4% |
| Mar 27, 2026 | RCKT | Rocket Pharmaceuticals, Inc. | Healthcare | Maintains | Buy → Buy | — | +0.4% | -19.6% |
| Mar 27, 2026 | MGTX | MeiraGTx Holdings plc | Healthcare | Maintains | Buy → Buy | — | +2.0% | +1.2% |
| Mar 25, 2026 | OCGN | Ocugen, Inc. | Healthcare | Maintains | Buy → Buy | — | +3.1% | +1.6% |
| Mar 25, 2026 | KDK | Kodiak AI, Inc. Common Stock | Technology | Maintains | Buy → Buy | — | +5.0% | +3.0% |
| Mar 25, 2026 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | Maintains | Buy → Buy | — | +1.7% | +6.7% |
| Mar 23, 2026 | ZURA | Zura Bio Limited | Healthcare | Maintains | Buy → Buy | — | +1.1% | +1.3% |
| Mar 20, 2026 | SLDB | Solid Biosciences Inc. | Healthcare | Maintains | Buy → Buy | — | +4.8% | -1.3% |
| Mar 20, 2026 | ANNX | Annexon, Inc. | Healthcare | Maintains | Buy → Buy | — | -0.7% | -6.9% |
| Mar 20, 2026 | ALMS | Alumis Inc. Common Stock | Healthcare | Maintains | Buy → Buy | — | -2.1% | -1.3% |